Fortis Healthcare Reports Mixed Financial Results Amid Rising Interest Expenses in March 2025
Fortis Healthcare reported its financial results for the quarter ending March 2025, achieving its highest net sales and profits in five quarters. However, the company faced challenges with rising interest expenses and a declining operating profit to interest ratio, indicating potential financial management difficulties.
Fortis Healthcare has recently reported its financial results for the quarter ending March 2025, revealing a complex picture of performance within the hospital industry. The company achieved its highest net sales in the last five quarters, reaching Rs 2,007.20 crore, alongside a notable operating profit of Rs 435.47 crore and a profit after tax of Rs 226.47 crore, both also marking peaks in the same timeframe. These figures indicate a positive near-term trend in sales and profitability.However, the financial landscape is not without challenges. The company experienced a significant rise in interest expenses, which reached Rs 67.56 crore, reflecting a quarter-on-quarter growth of 49.63%. This increase in interest costs suggests a rise in borrowings, which may impact the company's financial stability. Additionally, the operating profit to interest ratio has declined to its lowest point in five quarters at 6.45 times, indicating potential difficulties in managing interest obligations.
As a result of these dynamics, Fortis Healthcare has undergone an adjustment in its evaluation, reflecting the mixed outcomes of its recent financial performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
